Clinical Trial Update: Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma

View source ↗

Summary

An active clinical trial investigates dynamic monitoring of plasma circulating tumor DNA to prognosticate outcomes in patients with B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: B-Cell Non-Hodgkin Lymphoma | Status: ACTIVE_NOT_RECRUITING